» Articles » PMID: 35699185

Characterization of "ICU-30": A Binary Composite Outcome for Neonates With Critical Congenital Heart Disease

Overview
Date 2022 Jun 14
PMID 35699185
Authors
Affiliations
Soon will be listed here.
Abstract

Background Neonates with heart disease requiring cardiopulmonary bypass surgery are at high risk for mortality and morbidity. As it is rare, short-term mortality is difficult to use as a primary outcome for clinical studies. We proposed "ICU-30" as a binary composite "poor" outcome consisting of: (1) mortality within 30 days, (2) intensive care unit (ICU) admission ≥30 days, or (3) ICU readmission before day 30. To measure the utility of this composite, we assessed its prognostic properties for 6- and 12-month mortality. Methods and Results This was a retrospective single-center cohort study of neonates requiring cardiopulmonary bypass between 2013 and 2020. Mortality among patients with and without the ICU-30 outcome was compared using log-rank tests and Cox regression. Areas under the receiver operating characteristic curves assessed the ability of the composite to predict 12-month mortality. In 887 neonates, 232 (26.2%) experienced the ICU-30 outcome, with more prolonged ICU stays and readmissions (both ≥9%) than 30-day mortality (4.2%). ICU-30 was associated with higher rates of 6- and 12-month mortality (log-rank <0.001) and predicted 12-month mortality with area under the receiver operating characteristic of 0.81 (95% CI, 0.77-0.85). In 30-day survivors, both prolonged ICU stay (hazard ratio, 12.3; 95% CI, 6.70-22.7; <0.001) and ICU readmission (hazard ratio, 2.99; 95% CI, 1.17-7.63; =0.02) were associated with 12-month mortality. Conclusions ICU-30, a composite outcome of mortality, ICU length of stay, or ICU readmission by 30 days was associated with 6- and 12-month mortality in neonates requiring cardiopulmonary bypass. ICU-30 is captured in routine data collection and appears to be a valid binary patient-centered outcome.

Citing Articles

Textbook outcome for the Norwood operation-an informative quality metric in congenital heart surgery.

Prabhu N, Nellis J, Moya-Mendez M, Hoover A, Medina C, Meza J JTCVS Open. 2023; 15:394-405.

PMID: 37808016 PMC: 10556845. DOI: 10.1016/j.xjon.2023.05.003.

References
1.
Hanke S, Joy B, Riddle E, Ravishankar C, Peterson L, King E . Risk Factors for Unanticipated Readmissions During the Interstage: A Report From the National Pediatric Cardiology Quality Improvement Collaborative. Semin Thorac Cardiovasc Surg. 2017; 28(4):803-814. DOI: 10.1053/j.semtcvs.2016.08.011. View

2.
Ariti C, Cleland J, Pocock S, Pfeffer M, Swedberg K, Granger C . Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Am Heart J. 2011; 162(5):900-6. DOI: 10.1016/j.ahj.2011.08.003. View

3.
Dorobantu D, Ridout D, Brown K, Rodrigues W, Sharabiani M, Pagel C . Factors associated with unplanned reinterventions and their relation to early mortality after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2021; 161(3):1155-1166.e9. DOI: 10.1016/j.jtcvs.2020.10.145. View

4.
DeWitt A, Rossano J, Bailly D, Bhat P, Chanani N, Kirkland B . Predicting and Surviving Prolonged Critical Illness After Congenital Heart Surgery. Crit Care Med. 2020; 48(7):e557-e564. PMC: 7316132. DOI: 10.1097/CCM.0000000000004354. View

5.
Naim M, Gaynor J, Chen J, Nicolson S, Fuller S, Spray T . Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery. J Thorac Cardiovasc Surg. 2015; 150(1):169-78. PMC: 4936910. DOI: 10.1016/j.jtcvs.2015.03.045. View